Dr Jarad Martin
(MB ChB, FRANZCR, Director of Research, Honorary Associate Professor, Radiation Oncology)
|Department||Radiation Oncology / Physics|
|Research Areas||Diagnostics / Screening, Therapy and Treatment|
|Research Topics||Prostate Cancer, Side Effects / Adverse Reactions / Poisoning, Gastrointestinal Cancer|
|Research Types||Clinical Trials, Laboratory Research, Survey / Observational Research, Dissemination / Implementation|
Conjoint Associate Professor Jarad Martin is the Director of Research (Department of Radiation Oncology) and Radiation Oncologist at the Calvary Mater Newcastle, and Visiting Medical Officer at Genesis Cancer Care, Lake Macquarie Private Hospital.
With strong research interests in the areas of gastrointestinal and genitourinary oncology, A/Prof Martin has attracted over $6.5 million in competitive grant funding and has over 60 peer-reviewed publications to date. He is also Senior author on the Australasian guidelines for prostate cancer radiotherapy.
A/Prof Martin's professional leadership roles include: Faculty of Radiation Oncology; Chairperson Research Committee, Faculty of Radiation Oncology, Royal Australian and New Zealand College of Radiologists; Australia New Zealand Urological and Prostate Cancer Trials Group Scientific Advisory Committee; Trans-Tasman Radiation Oncology Group (TROG) Clinical Liaison Leader; and Deputy Chairperson, Hunter Cancer Research Alliance (HCRA) Implementation Science Flagship Committee.
More information about Dr Martins' academic achievements may be found here:
For a list of Dr Martin's publications, please click here
Getting to know you
What did you do before coming to work at Calvary Mater Newcastle?
I was a Radiation Oncologist at St Andrews Cancer Care Centre, Toowoomba; and a Radiation Oncology Clinical Research Fellow at Royal Brisbane Hospital.
When did you start doing research?
I've been involved with research right from my medical student days in the mid 1990's.
What research projects are you currently working on?
I'm involved with a range of projects, mainly looking at radiotherapy for prostate and gastrointestinal tumours. One study, PROMETHEUS, tries to use non-invasion radiotherapy to replace a procedure known as high dose rate brachytherapy for prostate cancer, which requires surgery. Another, SPARK, which is likely to commence later in 2015, tries to compress the standard 8 week course of prostate radiotherapy into 5 sessions.
What did you do before coming to work at CMN?
I've worked everywhere - New Zealand, England, Canada, Victoria, and Queensland.
What do you do to relax?
At this time of year, the Eurovision Song Contest dominates my relaxation time. I've also been bitten by the running bug.
What is the craziest thing you have ever had to do "in the name of research"?
Assess the effects of ethanol on human bladder function. As a university study, I was a most willing guineapig!